Myles Minter
Stock Analyst at William Blair
(1.48)
# 3,537
Out of 5,102 analysts
23
Total ratings
52.94%
Success rate
-0.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Market Perform | n/a | $7.90 | - | 2 | Nov 13, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $11.44 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $1.46 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $41.63 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.66 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $6.01 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $889.49 | - | 2 | Nov 1, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $2.07 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $7.52 | +844.15% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $29.63 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $445.93 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $267.28 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $4.02 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $412.63 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $79.14 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $154.75 | -25.04% | 1 | Feb 24, 2020 |
Korro Bio
Nov 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $7.90
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $11.44
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $1.46
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $41.63
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.66
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $6.01
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $889.49
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.07
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $7.52
Upside: +844.15%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $29.63
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $445.93
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $267.28
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $4.02
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $412.63
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $79.14
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $154.75
Upside: -25.04%